Publications by authors named "Jan Brandes"

Claim this Profile
L
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
Messoud Ashina, Stewart J Tepper, Jan Lewis Brandes, Uwe Reuter, Guy P Boudreau

Headache· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
Stewart J Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil

Cephalalgia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
Jan Lewis Brandes, David Kudrow, Paul P Yeung, Fumihiko Sakai, Ernesto Aycardi

Cephalalgia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, Marshall C Freeman, Peter J McAllister

Cephalalgia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna

Cephalalgia· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Peter J Goadsby, Koen Paemeleire, Gregor Broessner, Jan Brandes, Jan Klatt

Cephalalgia· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
Stewart J Tepper, Hans-Christoph Diener, Messoud Ashina, Jan Lewis Brandes, Deborah I Friedman

Neurology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, Uwe Reuter, Guy Boudreau

Cephalalgia· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps.
Rachel A Schroeder, Jan Brandes, Dawn C Buse, Anne Calhoun, Katharina Eikermann-Haerter

J Womens Health (Larchmt)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet

Cephalalgia· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
Egilius Lh Spierings, Jan Lewis Brandes, David B Kudrow, James Weintraub, Peter C Schmidt

Cephalalgia· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Stewart Tepper, Messoud Ashina, Uwe Reuter, Jan L Brandes, David Doležil

Lancet Neurol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in the Study of Neurological Illnesses.
Hrayr Attarian, Jan Brandes, Rima Dafer, Elizabeth Gerard, Barbara Giesser

Behav Neurol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine in women.
Jan Lewis Brandes

Continuum (Minneap Minn)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
Tony W Ho, Andrew P Ho, Bernard R Chaitman, Constance Johnson, Ninan T Mathew, Jan L Brandes

Headache· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence.
John F Rothrock, Roger K Cady, Sheena K Aurora, Jan Lewis Brandes, Judith A Myers

Curr Med Res Opin· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Roger K Cady, Sheena K Aurora, Jan L Brandes, John F Rothrock, Judith A Myers

Headache· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use.
Jan Lewis Brandes, Roger K Cady, Fred G Freitag, Timothy R Smith, Patricia Chandler

Headache· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine.
David J Hewitt, Vincent Martin, Richard B Lipton, Jan Brandes, Paulette Ceesay

Headache· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood maltreatment and migraine (part III). Association with comorbid pain conditions.
Gretchen E Tietjen, Jan L Brandes, B Lee Peterlin, Arnolda Eloff, Rima M Dafer

Headache· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification.
Gretchen E Tietjen, Jan L Brandes, B Lee Peterlin, Arnolda Eloff, Rima M Dafer

Headache· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter headache clinic survey.
Gretchen E Tietjen, Jan L Brandes, B Lee Peterlin, Arnolda Eloff, Rima M Dafer

Headache· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine and functional impairment.
Jan Lewis Brandes

CNS Drugs· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
E Anne MacGregor, Jan L Brandes, Stephen Silberstein, Slawomir Jeka, Piotr Czapinski

Headache· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allodynia in migraine: association with comorbid pain conditions.
Gretchen E Tietjen, Jan L Brandes, B Lee Peterlin, Arnolda Eloff, Rima M Dafer

Headache· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis